Results 41 to 50 of about 887,639 (384)

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

open access: yesNew England Journal of Medicine, 2016
BACKGROUND We examined the efficacy of olanzapine for the prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy. METHODS In a randomized, double-blind, phase 3 trial, we compared olanzapine with placebo, in combination ...
R. Navari   +9 more
semanticscholar   +1 more source

Management of chemotherapy induced emesis [PDF]

open access: yesArchive of Oncology, 2004
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently.
Roila Fausto
doaj   +1 more source

Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association

open access: yesNeurogastroenterology and Motility, 2019
The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence‐based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS ...
T. Venkatesan   +11 more
semanticscholar   +1 more source

Chemotherapy-induced nausea and vomiting: A narrative review to inform dietetics practice [PDF]

open access: yes, 2016
Chemotherapy-induced nausea and vomiting (CINV) are common nutrition-impact symptoms experienced by cancer patients. They exert a detrimental effect on dietary intake, risk of malnutrition and quality of life.
Isenring, Liz   +4 more
core   +3 more sources

Hirschsprung’s disease [PDF]

open access: yes, 2013
A 28-year-old, primagravida woman, gave birth to a boy at 40 gestational weeks. On delivery, the baby was found to have blood stained liquor. This was followed by non-bilious vomiting after feeds and a distended abdomen. He was transferred to NPICU at 36
Ellul, Sarah, Vanhear, Kay
core   +1 more source

Nausea control in mild head trauma patients: Effectiveness of metoclopramide and ondansetron in the emergency department in a double-blind study

open access: yesCaspian Journal of Internal Medicine, 2022
Background: Mild head trauma often causes several complications and disabilities including nausea and vomiting in hospitalized people. The aim of the present study was to compare the effectiveness of metoclopramide and ondansetron, and compare it with ...
Hamideh Feiz Disfani   +4 more
doaj  

Frequency of Predisposing Factor of Nausea and Vomiting After Chest Surgery Under General Anaesthesia [PDF]

open access: yes, 2019
Background: Postoperative nausea and vomiting are common and distressing postsurgical symptoms. These symptoms are of particular concern in outpatient surgery because they may require additional direct resources, such as supplies and antiemetic ...
Bhatti, S. U. (Sami)   +5 more
core   +2 more sources

IODINE for VOMITING [PDF]

open access: yesThe American Journal of the Medical Sciences, 1891
n ...
openaire   +2 more sources

Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome

open access: yesNeurogastroenterology and Motility, 2019
Cannabis is commonly used in cyclic vomiting syndrome (CVS) due to its antiemetic and anxiolytic properties. Paradoxically, chronic cannabis use in the context of cyclic vomiting has led to the recognition of a putative new disorder called cannabinoid ...
T. Venkatesan   +12 more
semanticscholar   +1 more source

Bimodal release ondansetron for acute gastroenteritis among adolescents and adults: A randomized clinical trial [PDF]

open access: yes, 2019
Importance: Vomiting resulting from acute gastroenteritis is commonly treated with intravenous antiemetics in acute care settings. If oral treatment were beneficial, patients might not need intravenous administered hydration or medication. Furthermore, a
Avarello, Jahn   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy